Sort   by:  
 Page size 
UnknownFCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.
Not available
S-EPMC5595863 | biostudies-literature
UnknownDetermining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer.
Not available
S-EPMC7750421 | biostudies-literature
UnknownIntractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1.
Not available
S-EPMC4105841 | biostudies-literature
UnknownA 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Not available
S-EPMC12820744 | biostudies-literature
UnknownValidation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest™ 95GC Breast in a multi‑institutional registry study.
Not available
S-EPMC10131261 | biostudies-literature
UnknownAssessment of ATP8B1 Deficiency in Pediatric Patients With Cholestasis Using Peripheral Blood Monocyte-Derived Macrophages.
Not available
S-EPMC5828058 | biostudies-literature
UnknownDistribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Not available
S-EPMC10758740 | biostudies-literature
Sort   by:  
 Page size